Skip to main content

Table 1 Clinico-pathological features of patient specimens

From: Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease

Tumour

1NM

Age

Gender

Dukes' stage

TNM stage

Differentiation

Vascular

invasion

2LNs harvested

LNs pos

Patient status

3Follow-up time

-

001NM

78

F

B

pT3, pN0, pR0

Poor

Absent

15

0

Well & symptom free

48

002T

002NM

91

M

B

pT3, pN0, pR0

Moderate

Absent

9

0

Deceased (recurrence)

35

003T

003NM

75

M

C1

pT3, pN1, pR0

Poor

Absent

10

3

Well & symptom free)

36

004T

004NM

74

F

C1

pT4, pN1, pR2

Poor

Present

11

3

Deceased (recurrence)

<1

005T

005NM

76

M

B

pT3, pN0, pR0

Poor

Absent

6

0

Well & symptom free

49

-

006NM

69

F

A

pT2, pN0, pR0

Well

Absent

11

0

Well & symptom free

40

-

007NM

52

M

C1

pT3, pN1, pR0

Poor

Absent

23

3

Well & symptom free

48

008T

008NM

63

F

C1

pT4, pN0, pR0

Poor

Absent

10

0

Deceased (recurrence)

40

009T

009NM

68

M

B

pT3, pN0, pR0

Poor

Absent

8

8

Well & symptom free

36

011T

011NM

77

M

C1

pT4,p N1, pR0

Poor

Absent

15

3

Well & symptom free

40

016T

016NM

61

M

C2

pT2, pN2, pR0

Moderate

Present

14

5

Well & symptom free

43

017T

017NM

65

F

B

pT3, pN0, pR0

Moderate

Absent

14

0

Well & symptom free

39

020T

020NM

65

F

B

pT3, pN0, pR0

Poor

Absent

12

0

Well & symptom free

36

021T

021NM

72

M

B

pT4, pN1, pR0

Moderate

Present

5

1

Well & symptom free

28

023T

023NM

59

M

B

pT3, pN0, pR0

Moderate

Absent

10

0

Well & symptom free

20

024T

024NM

41

F

C2

pT4, pN1, pRx

Well

Absent

15

2

Deceased (recurrence)

30

025T

-

82

M

B

pT4, pN0, pMx, pRx

Poor

Absent

7

0

Deceased (recurrence)

13

026T

026NM

76

F

A

pT2, pN0, pR0

Moderate

Absent

5

0

Deceased (recurrence)

36

028T

028NM

86

F

C1

pT3, pN1, pR0

Moderate

Absent

12

0

Well & symptom free

36

029T

029NM

71

F

B

pT3, pN0, pR0

Well

Absent

32

0

Well & symptom free

36

031T

031NM

82

M

C2

pT3, pN2, pR0

Poor

Present

11

3

Well & symptom free

36

032T

032NM

69

F

B

pT4, pN0, pR0

Moderate

Absent

11

0

Well & symptom free

23

033T

033NM

72

M

C1

pT4, pN1, pR0

Moderate

Absent

8

1

Well & symptom free

22

034T

034NM

58

M

C1

pT4, pN1, pR0

Moderate

Absent

5

3

Well & symptom free

25

-

035NM

77

F

B

pT3, pN0, pR0

Poor

Absent

7

0

Well & symptom free

25

036T

-

81

F

B

pT3, pN0, pR0

Moderate

Absent

13

0

Well & symptom free

21

037T

037NM

77

F

B

pT3, pN0, pR0

Well

Absent

7

0

Well & symptom free

19

038T

038NM

76

F

A

pT2, pN1, pR0

Poor

Absent

5

1

Well & symptom free

20

039T

039NM

75

F

B

pT3, pN0, pR0

Moderate

Absent

16

0

Well & symptom free

23

2012T

2012NM

62

M

C1

pT3, pN1, pR0

Poor

Present

18

3

Well & symptom free

20

2018T

2018NM

83

F

A

pT1, pN0, pR0

Moderate

Absent

6

0

Deceased (unrelated)

2

2022T

2022NM

56

M

B

pT3, pN0, pR0

Well

Present

20

0

Well & symptom free

20

2044T

2044NM

82

M

A

pT2, pN0, pR0

Moderate

Absent

10

0

Well & symptom free

21

-

2080NM

72

F

A

pT2, pN0, pR0

Moderate

Absent

5

0

Well & symptom free

21

2084T

-

38

M

B

ypT3, ypN0, ypR0

Poor

Absent

10

0

Well & symptom free

20

2085T

2085NM

78

F

C1

pT3, pN1, pR0

Moderate

Absent

11

1

Deceased (unrelated)

<1

  1. 1NM = normal mucosa; 2LN = lymph node; 3follow-up time in months